You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 2, February 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Images in Neurology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The "Eye-of-the-Tiger" Sign Is Not Pathognomonic of the PANK2 Mutation

Arch Neurol. 2006;63:292.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The "eye-of-the-tiger" sign refers to a specific pattern of hyperintensity within a hypointense globus pallidus that is seen on T2-weighted magnetic resonance (MR) imaging. The central hyperintensity is possibly due to tissue necrosis and edema, and the surrounding hypointensity, due to iron deposition. This appearance has been considered to be pathognomonic of Hallervorden-Spatz syndrome.1 The proposed new nomenclature suggests that the group of disorders with high iron in the basal ganglia be called neurodegeneration with brain iron accumulation (NBIA).2 The most prevalent form of NBIA is due to mutations in the pantothenate kinase 2 (PANK2) gene (chromosomal locus 20p13-p12.3) and is called pantothenate kinase–associated neurodegeneration (PKAN). Within this group the recognized forms include an early-onset, rapidly progressive, extrapyramidal syndrome often associated with pigmentary retinopathy; a later-onset syndrome with prominent behavioral difficulties and slower progression (atypical PKAN); and HARP (hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration). Neuroferritinopathy and aceruloplasminemia . . . [Full Text of this Article]

PATIENT 1


PATIENT 2

COMMENT

AUTHOR INFORMATION
Neeraj Kumar, MD; Christopher J. Boes, MD; Duscia Babovic-Vuksanovic, MD; Bradley F. Boeve, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurodegeneration With Pantothenate Kinase Syndrome: Retinal and Magnetic Resonance Imaging Findings
Gadodia et al.
Arch Neurol 2009;66:798-799.
FULL TEXT  

T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation
McNeill et al.
Neurology 2008;70:1614-1619.
ABSTRACT | FULL TEXT  

A neurological MRI menagerie
Schott
PN 2007;7:186-190.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.